UBS AM
PJP icon

UBS AM’s Invesco Pharmaceuticals ETF PJP Stock Holding History

UBS AM’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.92K Hold
50
– – ﹤0.01% 3373
2026
Q1 		$5.19K Hold
50
– – ﹤0.01% 3452
2025
Q4 		$5.23K Buy
+50
New +$5.03K ﹤0.01% 2972

Other funds holding PJP

PAM
Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
JGCM
Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

UBS AM's PJP Position: Q2 2026 in Review

UBS AM held its Invesco Pharmaceuticals ETF (PJP) position steady in Q2 2026 at 50 shares worth $5.92K. The position accounts for ﹤0.01% of the portfolio, ranked #3373.

UBS AM first reported a position in PJP in Q4 2025 and has held it in 3 quarters since. 117 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

  • UBS AM held 50 shares of Invesco Pharmaceuticals ETF worth $5.92K as of Q2 2026.
  • UBS AM left its Invesco Pharmaceuticals ETF share count unchanged in Q2 2026.
  • Invesco Pharmaceuticals ETF made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #3373 holding.
  • UBS AM first reported a position in Invesco Pharmaceuticals ETF in Q4 2025 and has held it in 3 quarters since.
  • 117 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.